— Know what they know.
Not Investment Advice

KDMN NYSE

Kadmon Holdings, Inc.
1W: +0.4% 1M: +7.2% 3M: +88.5% 1Y: +197.8% 3Y: +257.1% 5Y: +104.3%
$9.50
Last traded 2021-11-08 — delisted
NYSE · Healthcare · Biotechnology

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$8M +62.7% ▲
5Y CAGR: -25.3%
Gross Profit
$6M +65.2% ▲
5Y CAGR: -26.7%
Operating Income
-$102M -14.8% ▼
Net Income
-$109M -77.5% ▼
EPS (Diluted)
$-0.66 -43.5% ▼
EBITDA
-$107M -89.4% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2016FY2017FY2018FY2019FY2020
Revenue$26M$12M$1M$5M$8M
YoY Growth-27.1%-52.9%-88.6%+265.0%+62.7%
Cost of Revenue$4M$3M$682K$1M$2M
Gross Profit$22M$9M$714K$4M$6M
Gross Margin85.1%75.7%51.1%74.7%75.9%
R&D Expenses$36M$41M$49M$56M$65M
SG&A Expenses$106M$37M$38M$36M$0
Operating Expenses$142M$78M$87M$93M$109M
Operating Income-$120M-$69M-$86M-$89M-$102M
Operating Margin-458.8%-559.0%-6153.0%-1748.4%-1234.1%
Interest Expense$64M$4M$4M$3M$21K
Income Before Tax-$208M-$80M-$55M-$61M-$109M
Tax Expense$342K-$121K-$524K$46K-$182K
Net Income-$209M-$80M-$54M-$61M-$109M
Net Margin-801.2%-650.5%-3886.2%-1204.5%-1314.1%
EPS (Diluted)$-8.82$-1.39$-0.56$-0.46$-0.66
EBITDA-$127M-$74M-$50M-$57M-$107M
Shares Outstanding24M57M98M132M166M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms